Quality of Life Issues in Patients Undergoing Cytoreductive Surgery and HIPEC
Achieving or maintaining the quality of life of patients is an important goal especially if they are confronted with an end-stage oncologic disease. Peritoneal surface malignancy (PSM) as primary disease or secondary as peritoneal metastasis from different tumor origins is related to a bad prognosis. These patients suffer from ascites, fatigue, ileus, and cachexia, and in most of these patients, only palliative treatment is available. Extensive surgery combined with localized hyperthermic intraperitoneal chemotherapy (HIPEC) may lead to longer survival in selected patients. However, cytoreductive surgery (CRS) and HIPEC can be associated with severe complications and influences quality of life dramatically. In this chapter, we want to point out the quality of life issues in patients undergoing CRS and HIPEC.
KeywordsCytoreductive surgery Hyperthermic intraperitoneal chemotherapy Quality of life
- 1.Simkens GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, de Hingh IH. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2015;22(8):2656–62.CrossRefPubMedGoogle Scholar
- 3.Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients. Cancer. 2010;116(24):5608–18.CrossRefPubMedGoogle Scholar
- 4.Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, Gonzalez-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R. The American Society of Peritoneal Surface Malignancies (ASPSM) multiinstitution evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis. Ann Surg Oncol. 2014;21(13):4195–201.CrossRefPubMedGoogle Scholar
- 8.Polom K, Marano L, Roviello G, Petrioli R, Piagnerelli R, de Franco L, Marrelli D, Roviello F. Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: from treating the incurable to preventing recurrence. Int J Hyperth. 2015;32:1–7.Google Scholar